Abstract：Objective To observe the effect of 5-hudroxymethyl-2-furfural (5-HMF) on glycolipid metabolism and hepatic function in mice with type 2 diabetes mellitus (T2DM) and hepatic injury. Methods A low, a medium and a high 5-HMF dose group, a model group, and a control group were designed, with ten female ICR mice in each group. The low, medium and high dose group were given 0.27, 0.80 and 2.67 mg/kgbw 5-HMF, respectively, for 12 weeks; while the model group and the control group were given volume controlled deionized water. The model group and three dose groups were fed with high-fat and high-sugar food (36%), and the intraperitoneal injection of alloxan (60 mg/kgbw) was executed in the 10th and 11th week; the control group were fed with normal food. The body weight, blood glucose, blood lipid, and liver function of mice were determined regularly. The livers were stained by periodic acid Schiff and the changes in pathology were observed. Results Compared with the control group, the serum levels of glucose (GLU), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) were significantly higher in the model group (P<0.05). Compared with the model group, the AST level in the low and high 5-HMF dose group, and the LDH level in the low, medium and high 5-HMF dose group, were significantly lower (P<0.05). There were no significant differences in the levels of GLU, total cholesterol, LDL-C, triacylglycerol, HDL-C and ALT between the model group and the three dose groups (P>0.05). Moderate to severe vacuolar degeneration was observed in the model group, while mild vacuolar degeneration was observed in the high dose group. Medium or large amount of hepatic glycogen granules were observed in the high dose group and the model group. Conclusion Under the conditions of this experiment, 5-HMF does not show any obvious function of reducing blood glucose and lipid in the mice with T2DM and liver injury, but show some protective effects on liver function．
鹿伟, 夏勇, 张世鑫, 宋燕华, 蔡德雷, 徐彩菊, 赵李丽. 5-HMF对早期2型糖尿病合并肝损伤小鼠糖脂代谢和肝功能影响的研究[J]. 预防医学, 2021, 33(11): 1109-1112.
LU Wei, XIA Yong, ZHANG Shixin, SONG Yanhua, CAI Delei, XU Caiju, ZHAO Lili. Effects of 5-HMF on glycolipid metabolism and hepatic function in mice with diabetes and hepatic injury. Preventive Medicine, 2021, 33(11): 1109-1112.
[1] 关责彬,张瑜,刘迪,等.中药与食品中共性成分5-羟甲基-2-糠醛的生物活性及其安全性研究进展[J].中国药师,2018,21(8):1456-1459. [2] 徐芳辉,胡志成,易新宜,等.5-羟甲基糠醛在中药质量标准中的应用现状[J].中国医药导报,2017,14(15):47-50. [3] FARAG M R,ALAGAWANY M,BIN-JUMAH M,et al.The toxicological aspects of the heat-borne toxicant 5-hydroxymethylfurfural in animals:a review[J].Molecules,2020,25(8):1-13. [4] U.S. Department of Health and Human Services. NTP Technical report on the toxicology and carcinogenesis studies of 5-(hydroxymethyl)-2-furfural (CAS No. 67-47-0) in F344/N rats and B6C3F1 mice (gavage studies)[R/OL].[2021-09-10]. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/TR554.pdf [5] 张欣,廖祥伟,吴松,等.5-羟甲基-2-呋喃甲醛衍生物的合成及降血糖活性评价[J].中国药物化学杂志,2012,22(5):349-355. [6] 丁霞,王明艳,余宗亮,等.山茱萸中5-羟甲基糠醛的分离鉴定及生物活性研究[J].中国中药杂志,2008,33(4):392-396,484. [7] 裴天仙,郭景明,王春雨,等.6种2型糖尿病动物模型中生化和病理改变的比较[J].药物评价研究,2020,43(9):1740-1746. [8] GEMA A,FRACISCO J M.Estimation of dietary intake of 5-hydroxymethylfurfural and related substances from coffee to Spanish population[J].Food Chem Toxicol,2010,48(2):644-649. [9] KLAUS A,RAINER G,KATHARINA B,et al.Toxicology and risk assessment of 5-hydroxymethylfurfural in food[J].Mol Nutr Food Res,2011,55(5):667-678. [10] 李丹丹,刘佳佳,吴玉泓,等.黄芪多糖联合二甲双胍对衰老2型糖尿病模型小鼠肝脏糖脂代谢的影响[J].中国中医药信息杂志,2019,26(2):47-51. [11] 许芳芳,王楠,李刚强,等.2型糖尿病小鼠模型的建立与评价[J].中国医学科学院学报,2017,39(3):324-329. [12] 吴胜,蔡双鹏,李小枫,等.丹参酮I对2型糖尿病ICR小鼠抗糖作用的研究[J].安徽医科大学学报,2016,51(9):1286-1291. [13] 刘安军,王秀丽,陈影,等.胶原蛋白多肽-铬 (III)螯合物对四氧嘧啶致小鼠肝脏损伤的保护作用[J].营养学报,2006,28(6):487-489,493. [14] 严峻,夏勇,张世鑫,等.金樱子、枳犋子、牛磺酸混合物对小鼠酒精性肝损伤的保护作用研究[J].预防医学,2020,32(9):968-970.
